MANDELIA ASHISH (VP, Controller) sold 3.3% of their position (1.79K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/16/2025ACC: 0001104659-25-004185
Officer· VP, Controller
Since Jan 2020
-1.79K
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.78K acquired · 6.57K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.78K
Price / share
—
Trade value
—
% of position
9.7%
1/14/2025
49.40K→54.18K
Common Stock
Direct
Shares
−1.79K
Price / share
$0.63
Trade value
$1.13K
% of position
3.3%
1/15/2025
54.18K→52.39K
Total
Net shares
+2.99K
Net value
-$1.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2025 | M · Option Exercise | +4.78K | — | — | 9.7% | 49.40K | 54.18K |
| Common Stock Direct | 1/15/2025 | S · Sale | −1.79K | $0.63 | $1.13K | 3.3% | 54.18K | 52.39K |
| Total | +2.99K | -$1.13K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
4.78K shares
Shares
−4.78K
Strike price
Held after
4.78K
Exercisable
—
1/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock4.78K shares | 1/14/2025 | M · Option Exercise | −4.78K | — | 4.78K |